Ultralife Corporation ULBI

Industrials · Electrical Equipment & Parts · United States

https://www.ultralifecorporation.com

Company Profile ↓

$5.94

-13.28% 1Y

Mkt Cap$98.98M

P/E-15.23

P/B0.73

52W High$7.95

52W Low$5.05

Book Value$7.78

EPS (TTM)$-0.39

Company Overview

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle amplifier-adaptors, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. The company sells its products under the Ultralife, Ultralife HiRate, Ultralife Thin Cell, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, Excell Battery Group, Criterion Gauge, and POW-R BMS brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. It serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.36.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $191.16M (+16.2% YoY); net profit $-5.90M.
Trailing 12 Months Year-on-year growth — revenue -1.3%, earnings +200.0%.
5-Year Trend Long-term compounding — revenue CAGR 1.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	1.44%
1 Year:	-1.30%

Compounded Profit Growth

5 Years:	-
1 Year:	200.00%

Stock Price Performance

1 Year:	-13.28%
6 Months:	+11.44%
3 Months:	-10.81%
1 Month:	-6.46%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 31% of range

$5.05 $7.95

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)38.42 · Neutral

Price Performance

1M-6.46%

3M-10.81%

6M+11.44%

1Y-13.28%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Generates positive free cash flow.

CONS

Trading 25.3% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-15.23

Industry PE

26.00

Forward P/E

6.60

PEG Ratio

3.81

Book Value

$7.78

Price to Book

0.73

P/S

0.50

EV/EBITDA

10.61

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

1.44%

Profit 5Y

Revenue (YoY)

-1.30%

Earnings (YoY)

200.00%

Profitability & Returns

ROCE

3.50%

ROE

-4.91%

ROA

2.10%

Profit Margin

-3.50%

Op Margin

9.01%

Gross Margin

24.38%

EPS (Latest Qtr)

$-0.03

EPS (TTM)

$-0.39

Balance Sheet & Liquidity

Debt/Equity

0.36

Quick Ratio

1.11

Current Ratio

2.87

Debt

$47.51M

Total Assets

$220.63M

Current Assets

$110.10M

Working Capital

$68.47M

Ownership

Promoter Holding

3.22%

Chg in Prom Hold

-0.00%

FII / Inst Holding

73.89%

Chg in FII Hold

-0.07%

Financial Snapshot

Enterprise Value

$98.98M

Total Revenue (TTM)

$187.24M

EBITDA

$12.73M

Free Cash Flow

$2.34M

Operating Cash Flow

$5.13M

Shares Outstanding

16.66M

Gross Margin

24.38%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Industrials).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	ULBI Ultralife Corporation	5.94	-15.23	$98.98M	0.00%	3.50%	-4.91%	1.44%	-
2	SPCX Space Exploration Technologies Corp. R3KAIDEFENCE	153.47	-139.52	$1.16T	0.00%	-3.22%	-11.95%	34.08%	-3.34%
3	CAT Caterpillar Inc. SPXR3K	822.48	35.47	$378.07B	0.79%	17.98%	56.97%	2.29%	5.24%
4	GE GE Aerospace SPXR3KDEFENCE	334.91	39.40	$347.49B	0.60%	9.52%	48.23%	-7.42%	-5.36%
5	RTX RTX Corporation SPXR3KDEFENCE	198.81	35.06	$267.95B	1.51%	8.28%	12.27%	2.61%	2.62%
6	GEV GE Vernova Inc. SPXR3KAI	971.31	27.86	$258.69B	0.22%	6.30%	82.58%	8.68%	-
7	DE Deere & Company SPXR3K	680.73	37.88	$183.54B	0.95%	12.53%	18.24%	3.43%	5.10%
8	UNP Union Pacific Corporation SPXR3K	288.45	23.38	$171.36B	2.01%	15.22%	39.70%	2.30%	7.77%
9	BA The Boeing Company SPXR3KDEFENCE	210.73	75.80	$166.43B	0.00%	-9.01%	-	1.67%	-3.28%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Jun 2013	Sep 2013	Mar 2014	Jun 2014	Sep 2014	Mar 2015	Jun 2015	Sep 2015	Mar 2016	Jun 2016	Sep 2016	Apr 2017	Jul 2017	Oct 2017	Apr 2018	Jul 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	17.28M	20.36M	15.29M	15.20M	16.06M	19.18M	18.95M	19.04M	20.83M	20.37M	19.63M	22.04M	19.94M	21.05M	-	-	-	-	-	-	25.81M	-	-	25.97M	26.77M	21.76M	30.37M	32.13M	33.23M	31.92M	42.69M	39.49M	41.93M	42.98M	35.69M	50.75M	48.56M	43.37M	48.48M	47.45M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38.00M	36.96M	33.75M	36.42M	37.34M
Gross Profit	4.52M	6.13M	4.33M	4.21M	4.49M	6.01M	5.86M	5.90M	6.41M	5.90M	6.00M	6.89M	6.22M	6.25M	7.28M	6.55M	6.04M	5.08M	8.87M	7.86M	7.33M	7.96M	6.51M	6.98M	7.27M	5.11M	6.96M	7.65M	6.71M	7.44M	10.59M	9.77M	11.47M	11.56M	8.68M	12.74M	11.60M	9.62M	12.06M	10.11M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.35M	9.35M	10.57M	10.48M	10.32M
Operating Income	-1.87M	652.00K	-1.10M	-1.32M	-55.00K	822.00K	817.00K	1.17M	482.00K	499.00K	1.14M	1.84M	1.32M	1.26M	2.36M	1.63M	1.50M	548.00K	3.04M	1.31M	1.49M	2.29M	707.00K	952.00K	1.09M	-779.00K	-295.00K	793.00K	-586.00K	26.00K	3.67M	2.13M	4.06M	3.92M	511.00K	3.40M	2.26M	-951.00K	1.57M	-215.00K
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.83M	3.52M	660.00K	-7.96M	1.53M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.03M	992.00K	992.00K	937.00K	868.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.45M	1.11M	-1.75M	-10.21M	-663.00K
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	567.00K	243.00K	-504.00K	-2.75M	-192.00K
Net Income	-2.07M	644.00K	-1.29M	-1.36M	-323.00K	533.00K	788.00K	1.05M	299.00K	446.00K	1.02M	1.66M	1.09M	1.10M	2.15M	1.63M	1.41M	425.00K	2.26M	898.00K	1.06M	1.66M	407.00K	671.00K	811.00K	-585.00K	-168.00K	512.00K	-239.00K	-346.00K	3.34M	1.33M	2.89M	2.97M	258.00K	1.86M	879.00K	-1.22M	-7.42M	-451.00K
Diluted EPS	-0.12	0.04	-	-0.08	-	0.03	0.05	0.07	0.02	0.03	0.07	0.11	0.07	0.07	0.13	0.10	0.09	0.03	14.00	6.00	7.00	10.00	3.00	4.00	0.05	0.05	-0.01	0.03	0.03	0.03	0.03	0.08	0.08	0.18	0.02	0.11	0.05	-0.07	-0.45	-0.03
R&D Expense	1.67M	1.42M	1.44M	1.56M	1.01M	1.36M	1.33M	1.22M	1.66M	1.43M	1.36M	1.14M	1.19M	1.35M	1.10M	1.22M	1.10M	1.04M	1.59M	2.03M	1.55M	1.27M	1.61M	1.65M	1.85M	1.72M	1.86M	1.67M	1.90M	2.03M	1.78M	1.87M	1.76M	2.00M	2.10M	2.40M	2.32M	2.85M	-	2.96M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	154.29M	166.82M	135.74M	101.66M	78.83M	66.49M	76.43M	82.46M	85.53M	87.19M	106.80M	107.71M	-	131.84M	158.64M	164.46M	191.16M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	102.44M	119.44M	122.14M	145.14M
Gross Profit	35.31M	46.66M	34.19M	28.73M	22.62M	19.35M	23.32M	25.11M	26.23M	25.58M	31.16M	29.16M	-	29.40M	39.20M	42.31M	46.02M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	29.27M	29.73M	32.35M	39.74M
Operating Income	-3.55M	11.86M	2.41M	-114.00K	-624.00K	-1.44M	3.33M	3.76M	6.48M	6.55M	7.37M	5.70M	-	129.00K	9.47M	9.96M	6.28M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	4.96M	15.04M	14.40M	1.05M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	951.00K	2.02M	1.94M	3.95M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-446.00K	9.12M	8.30M	-8.40M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-326.00K	1.95M	1.89M	-2.45M
Net Income	-9.24M	-6.18M	-2.08M	-1.60M	-926.00K	-2.12M	2.87M	3.51M	7.65M	24.93M	5.21M	5.23M	-	-119.00K	7.20M	6.31M	-5.90M
Diluted EPS	-0.54	-0.36	-0.12	-0.09	-0.05	-	0.17	0.23	0.48	1.53	32.00	0.33	-	-0.01	0.44	0.38	-0.35
R&D Expense	9.45M	8.76M	8.59M	7.22M	5.86M	5.33M	5.60M	5.95M	4.74M	4.51M	6.80M	5.95M	6.83M	7.08M	7.53M	8.27M	10.40M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	114.83M	100.81M	97.72M	90.19M	87.64M	81.52M	84.74M	97.19M	120.85M	144.56M	137.70M	-	168.43M	178.28M	220.45M	216.91M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	78.99M	90.20M	97.16M	105.80M
Cash & Equivalents	1.88M	6.09M	4.64M	5.32M	9.66M	16.07M	17.71M	14.39M	-	18.24M	25.58M	7.13M	10.56M	-	5.63M	10.20M	6.85M	9.35M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	41.19M	42.22M	51.36M	54.01M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27.78M	31.76M	29.37M	33.95M
Total Liabilities	-	-	-	-	-	16.55M	15.73M	15.51M	16.88M	18.14M	16.39M	34.81M	20.78M	-	52.03M	52.85M	86.26M	86.78M
Current Liabilities	-	-	36.34M	23.16M	19.89M	12.02M	11.21M	10.85M	11.33M	14.24M	15.39M	17.19M	18.71M	-	28.91M	23.73M	29.29M	37.33M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	15.78M	0	-	19.31M	23.62M	51.50M	45.53M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21.31M	25.62M	54.25M	49.65M
Total Equity	88.15M	78.11M	73.77M	73.26M	73.52M	73.74M	72.03M	66.16M	68.03M	79.20M	104.55M	109.73M	116.80M	-	116.28M	125.33M	134.00M	130.00M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20.57M	20.78M	21.07M	21.09M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	2.03M	10.91M	10.96M	4.77M	6.90M	3.67M	8.55M	7.65M	7.27M	10.89M	-2.97M	21.72M	-	-1.26M	1.93M	16.64M	10.99M
Investing Cash Flow	-8.80M	-1.95M	-2.00M	-812.00K	-269.00K	-1.39M	-2.91M	-11.08M	-1.39M	-4.18M	-31.53M	-2.98M	-	-1.68M	-2.55M	-49.95M	-3.87M
Financing Cash Flow	10.76M	-10.63M	-8.60M	115.00K	12.00K	-751.00K	-8.87M	-175.00K	1.40M	1.17M	16.12M	-15.69M	-	518.00K	5.49M	29.86M	-4.68M
Capital Expenditure	-1.82M	-1.76M	-2.36M	-2.69M	-766.00K	-1.65M	-2.91M	-1.22M	-1.39M	-4.18M	-6.28M	-3.10M	-	-1.68M	-2.55M	-1.93M	-3.87M
Free Cash Flow	212.00K	9.15M	8.60M	2.08M	6.13M	2.01M	5.64M	6.43M	5.88M	6.70M	-9.25M	18.62M	-	-2.94M	-623.00K	14.70M	7.12M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-2.42M	4.87M	-3.46M	2.44M
Share Buybacks	3.33M	-	-	-	-	-	9.39M	607.00K	-	742.00K	1.96M	0	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	22.9%	28.0%	25.2%	28.3%	28.7%	29.1%	30.5%	30.4%	30.7%	29.3%	29.2%	27.1%	-	22.3%	24.7%	25.7%	24.1%
Operating Margin %	-2.3%	7.1%	1.8%	-0.1%	-0.8%	-2.2%	4.4%	4.6%	7.6%	7.5%	6.9%	5.3%	-	0.1%	6.0%	6.1%	3.3%
Net Margin %	-6.0%	-3.7%	-1.5%	-1.6%	-1.2%	-3.2%	3.8%	4.3%	8.9%	28.6%	4.9%	4.9%	-	-0.1%	4.5%	3.8%	-3.1%
ROE %	-11.8%	-8.4%	-2.8%	-2.2%	-1.3%	-2.9%	4.3%	5.2%	9.7%	23.8%	4.7%	4.5%	-	-0.1%	5.7%	4.7%	-4.5%
ROCE %	-	15.1%	3.1%	-0.1%	-0.8%	-1.9%	4.7%	5.1%	7.8%	6.2%	5.8%	4.8%	-	0.1%	6.1%	5.2%	3.5%

Shareholding Pattern

Insiders

3.22%

Institutions

73.89%

Public Float

76.35%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Visionary Wealth Advisors	6.66%	1.11M	$6.27M
2	Dimensional Fund Advisors LP	5.78%	963.73K	$5.45M
3	Janney Montgomery Scott LLC	3.36%	560.35K	$3.17M
4	Vanguard Capital Management LLC	2.79%	464.73K	$2.63M
5	Truffle Hound Capital, LLC	1.50%	250.00K	$1.41M
6	RBF Capital, LLC	1.31%	218.71K	$1.24M
7	Renaissance Technologies, LLC	1.03%	171.79K	$970.61K
8	Blackrock Inc.	0.93%	154.41K	$872.39K
9	Connor Clark & Lunn Investment Management Ltd	0.93%	155.04K	$875.99K
10	Raymond James Financial, Inc.	0.82%	136.70K	$772.33K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ULBI

Google News Wed, 12 Aug 2026

Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip - finance.yahoo.com

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPNEwxSV9taXdYdEZqbWdZelpsMTNKUTlSbmYzTjQ1dkNxc2RpV1N5MlE0M24xRnd3aWNTUGpUTUZGOW4tUWp4NVl6U0UtZlBFRmhTcnBWMEtRdkUySlVNTjNGa1NIaWp2aThlcUZPMDl1YUlhbVItOEFVcXdSQkFtNThReWc3RzNMOHpTWl…

Google News Sun, 09 Aug 2026

Ultralife (ULBI) Stock Rallies On Profit Rebound As One Off Boosts Linger - simplywall.st

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNT3dURjdFU2Z6dll4c2lRNDFFa2ZyZjBGX0l4RElabktUdlhRbHF3QkZDbEZFNVRNR1pWVTMwYWZIbXFBejhsbHlONC1BUjNXeUpuUFE1VUNaOWpodFlhQnRncFRvdGtURzQwbDhrVXVXelBuZWlBaVM5TTVQMjZKZEJfM2swbTBFZFVCeE…

Google News hu, 03 Sep 2026

Trading the Move, Not the Narrative: (ULBI) Edition - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNaVgxREM3dGNHc1ZTN215LUluekRBQ0Zfa3dZRWcxbXpFeUZIMFlZMUFwc3FNQ2Fja1puQWo5bjBoWmNmR2FsaVdJNkNsYkY4UEkyS3N1bkxDa1ZWRWZseGI2eEl5V3d3SUJ6aGJWWXAtellvOWRoVlhsMENxcGpYRnhrb1REVEVlNUdlM1…

Google News ue, 26 May 2026

ULBI - Ultralife Corp Stock Price and Quote - Finviz

<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE9ndEU5bjJ1ZXdnWUtJNnVsVzEtOTVHOXBMbEw5Z3B4V1Jrdmd5OXc5Mk9JV0xEUkRLQzVQSkFtMXRHZ2ltTlE?oc=5" target="_blank">ULBI - Ultralife Corp Stock Price and Quote</a>  <font color="…

Google News hu, 16 Jul 2026

Should I buy Ultralife (ULBI) - Zacks Investment Research

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1EMHBNQ2ZnQXNrX1JkMEZwMGhlWHJKYXg5RkM5cHhhdDRFR3NRVlM3N3J4WGEyWjl0c0VsMHhJdlJBRmdSc3N0cURuVFJOMnNyZHdTWFlEWGoxNVZSWWdrNTNqQ3dnVnFYUUhqMg?oc=5" target="_blank">Should I buy Ultralif…

Google News Wed, 02 Sep 2026

Ultralife Corporation (NASDAQ: ULBI) Share Price, ULBI Stock News, ULBI Share Price & Updates - kalkine.com.au

<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBib0tUZU5tNzFlZjA2ajhTeTNZRTBweUNwUUtlQXF3UkdQbE1abFJfUnJHU0lKYTZ1VDNuSUNJaS1pX0E5Z0pwZGdJd3oyVmFrd1N6VjVR?oc=5" target="_blank">Ultralife Corporation (NASDAQ: ULBI) Share Price, U…

ULBI — Frequently Asked Questions

What is the current share price of Ultralife Corporation (ULBI)?

As of 2026-09-19 21:16 PDT, Ultralife Corporation (ULBI) trades at $5.94 on NasdaqGM. Its 52-week range is $5.05 to $7.95.

What is the market capitalisation of ULBI?

Ultralife Corporation (ULBI) has a market capitalisation of $98.98M on NasdaqGM.

What is the P/E ratio of ULBI?

ULBI trades at a trailing price-to-earnings (P/E) ratio of -15.23. The industry average P/E is 26.00. Its price-to-book (P/B) ratio is 0.73.

What is the return on equity (ROE) of ULBI?

ULBI has a return on equity (ROE) of -4.91%. Its return on capital employed (ROCE) is 3.50%.

Is ULBI a good stock to buy?

This page provides a data-driven analysis of Ultralife Corporation (ULBI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Industrials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Ultralife Corporation ULBI

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip - finance.yahoo.com

Ultralife (ULBI) Stock Rallies On Profit Rebound As One Off Boosts Linger - simplywall.st

Trading the Move, Not the Narrative: (ULBI) Edition - Stock Traders Daily

ULBI - Ultralife Corp Stock Price and Quote - Finviz

Should I buy Ultralife (ULBI) - Zacks Investment Research

Ultralife Corporation (NASDAQ: ULBI) Share Price, ULBI Stock News, ULBI Share Price & Updates - kalkine.com.au

ULBI — Frequently Asked Questions

What is the current share price of Ultralife Corporation (ULBI)?

What is the market capitalisation of ULBI?

What is the P/E ratio of ULBI?

What is the return on equity (ROE) of ULBI?

Is ULBI a good stock to buy?

Explore More